SCHEMBL130707

SCHEMBL130707

CCC(C)(C)CC(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.43
HSD17B10 Q99714 2/20 0.40
MGAM O43451 2/20 0.40
GAA P10253 2/20 0.40
SI P14410 2/20 0.40
MGAM2 Q2M2H8 2/20 0.40
TET2 Q6N021 1/20 0.38
CA12 O43570 5/20 0.37
CA14 Q9ULX7 5/20 0.37
RECQL P46063 2/20 0.37
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 2/20 0.34
USP2 O75604 1/20 0.34
CA7 P43166 2/20 0.33
CA9 Q16790 2/20 0.33
CA2 P00918 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18753257 0.89 TSHR (0.39) TSHRHSD17B10MGAMGAASI
SCHEMBL22005680 0.88 TSHR (0.34) TSHRHSD17B10MGAMGAASI
SCHEMBL667630 0.87 TSHR (0.50) TSHRHSD17B10MGAMGAASI
SCHEMBL15095640 0.85 ALDH1A1 (0.36) TSHRHSD17B10MGAMGAASI
SCHEMBL6988854 0.81 TSHR (0.40) TSHRHSD17B10MGAMGAASI
SCHEMBL2526094 0.81 TSHR (0.40) TSHRHSD17B10MGAMGAASI
SCHEMBL7672928 0.80 KDM4E (0.30) KDM4ETDP1
SCHEMBL7256439 0.80 TSHR (0.43) TSHRHSD17B10MGAMGAASI
SCHEMBL2151978 0.80 TSHR (0.43) TSHRHSD17B10MGAMGAASI
SCHEMBL544329 0.80 TSHR (0.33) TSHRKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115819234-B Method for olefin carbonylation reaction 浙江新和成股份有限公司 2025-04-29 CN disclosed
CN-118164899-A Ligand, catalytic system and application thereof 浙江新和成股份有限公司 2024-06-11 CN disclosed
US-11833792-B2 Laminate for molding MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-12-05 US disclosed
US-20230373932-A1 DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2023-11-23 US disclosed
US-20230296981-A1 RESIST MATERIAL AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-21 US disclosed
US-20230296980-A1 RESIST MATERIAL AND PATTERN FORMING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-21 US disclosed
CN-116139939-A Catalyst system and method for carbonylation reaction 浙江新和成股份有限公司 2023-05-23 CN disclosed
CN-115819234-A Method for olefin carbonylation reaction 浙江新和成股份有限公司 2023-03-21 CN disclosed
CN-109952360-B Quantum dot dispersion, self-luminous photosensitive resin composition, color filter manufactured using the same, and image display device 东友精细化工有限公司 2022-03-22 CN disclosed
CN-109810589-A Light converts resin combination, light conversion layer folds substrate and image display device 东友精细化工有限公司 2019-05-28 CN disclosed
WO-2008051406-A2 SUBSTITUTED IMIDAZOLES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS MERCK & CO., INC. (US) 2008-05-02 WO disclosed
WO-2008051404-A2 SUBSTITUTED IMIDAZOLES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS MERCK & CO., INC. (US) 2008-05-02 WO disclosed
WO-2008051405-A1 SUBSTITUTED IMIDAZOLES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS MERCK & CO., INC. (US) 2008-05-02 WO disclosed
US-20070172761-A1 Positive photosensitive composition and method of forming pattern using the same FUJIFILM CORPORATION (JP) 2007-07-26 US disclosed
EP-1747211-A1 PROCESS FOR PREPARING UNSATURATED LACTONES Akzo Nobel N.V. (NL) 2007-01-31 EP disclosed
WO-2005113533-A1 PROCESS FOR PREPARING UNSATURATED LACTONES SYMRISE GMBH & CO. KG (DE) 2005-12-01 WO disclosed
EP-0889945-B1 FRAGRANT MACROCYCLIC LACTONES FIRMENICH & CIE (CH) 2002-12-04 EP disclosed
EP-0889945-A1 FRAGRANT MACROCYCLIC LACTONES FIRMENICH SA (CH) 1999-01-13 EP disclosed
US-5792740-A PERFUMES; MUSKY ODORS FIRMENICH SA (CH) 1998-08-11 US disclosed
WO-1997032948-A1 FRAGRANT MACROCYCLIC LACTONES FIRMENICH S.A. (CH) 1997-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230373932-A1 DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF REN, PKD2, ALPI TSHR 4131/4885HSD17B10 1351/4885MGAM 1272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.